Spyre Therapeutics SYRE
NASDAQ SYRE
$90.33 -2.00 (-2.17%)
At close: Oct 23, 2026 · 4:00 PM EDT

Spyre Therapeutics (SYRE) Sale and Maturity of Investments (2016 - 2026)

Updated

Analysis

Spyre Therapeutics (SYRE) Sale and Maturity of Investments (2016 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Spyre Therapeutics 7.95 Bn 4.83 Bn - 109.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 109.44 Mn
Mar 31, 2026 107.75 Mn
Dec 31, 2025 94.30 Mn
Sep 30, 2025 99.19 Mn
Jun 30, 2025 106.87 Mn
Mar 31, 2025 71.38 Mn
Dec 31, 2024 62.55 Mn
Sep 30, 2024 77.79 Mn
Jun 30, 2024 57.88 Mn
Mar 31, 2024 47.75 Mn
Dec 31, 2023 18.90 Mn
Jun 30, 2023 3.25 Mn
Mar 31, 2023 17.75 Mn
Dec 31, 2022 18.50 Mn
Sep 30, 2022 23.75 Mn
Jun 30, 2022 25.00 Mn
Mar 31, 2022 29.30 Mn
Dec 31, 2021 22.91 Mn
Sep 30, 2021 32.12 Mn
Jun 30, 2021 22.00 Mn
API Access

Spyre Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=SYRE&period=max&api_key=YOUR_API_KEY